Rob Stein

Rob Stein is a correspondent and senior editor on NPR's science desk.

An award-winning science journalist with more than 25 years of experience, Stein mostly covers health and medicine. He tends to focus on stories that illustrate the intersection of science, health, politics, social trends, ethics, and federal science policy. He tracks genetics, stem cells, cancer research, women's health issues and other science, medical, and health policy news.

Before NPR, Stein worked at The Washington Post for 16 years, first as the newspaper's science editor and then as a national health reporter. Earlier in his career, Stein spent about four years as an editor at NPR's science desk. Before that, he was a science reporter for United Press International (UPI) in Boston and the science editor of the international wire service in Washington.

Stein is a graduate of the University of Massachusetts, Amherst. He completed a journalism fellowship at the Harvard School of Public Health, a program in science and religion at the University of Cambridge, and a summer science writer's workshop at the Marine Biological Laboratory in Woods Hole, Mass.

Stein's work has been honored by many organizations, including the National Academy of Sciences, the American Association for the Advancement of Science and the Association of Health Care Journalists.

Pages

Shots - Health News
4:24 pm
Tue December 2, 2014

FDA Considers Allowing Blood Donations From Some Gay Men

Several countries, including Australia, Japan and Great Britain, already encourage blood donations from some gay men.
Kevin Curtis Getty Images/Science Photo Library

Originally published on Wed December 3, 2014 9:50 am

The Food and Drug Administration is considering revising a ban on blood donations from men who have had sex with other men.

An FDA advisory committee Tuesday mulled the issues raised by changing the policy, which has been in effect since the early 1980s.

Read more
Shots - Health News
11:16 am
Tue November 25, 2014

Treatment For HIV Runs Low In U.S., Despite Diagnosis

A pharmacist pours Truvada pills, an HIV treatment, back into the bottle at Jack's Pharmacy in San Anselmo, Calif.
Justin Sullivan Getty Images

Originally published on Wed November 26, 2014 10:35 am

About two-thirds of Americans who are infected with the virus that causes AIDS aren't getting treated for it.

The finding comes from an analysis just released by the Centers for Disease Control and Prevention showing that more needs to be done to make sure people infected with the human immunodeficiency virus get proper treatment.

Read more
Shots - Health News
1:03 am
Mon November 10, 2014

Combining The DNA Of Three People Raises Ethical Questions

Daniel Horowitz for NPR

Originally published on Mon November 10, 2014 3:03 pm

In a darkened lab in the north of England, a research associate is intensely focused on the microscope in front of her. She carefully maneuvers a long glass tube that she uses to manipulate early human embryos.

"It's like microsurgery," says Laura Irving of Newcastle University.

Irving is part of a team of scientists trying to replace defective DNA with healthy DNA. They hope this procedure could one day help women who are carrying genetic disorders have healthy children.

Read more
Research News
4:37 am
Wed October 15, 2014

Study Finds Human Stem Cells May Help To Treat Patients

Copyright 2014 NPR. To see more, visit http://www.npr.org/.

Transcript

AUDIE CORNISH, HOST:

For the first time ever, scientists are reporting that human embryonic stem cells may be helping treat patients. In the medical journal The Lancet, researchers describe how the cells seem to help restore eyesight to some blind people.

Read more
Shots - Health News
4:56 pm
Tue October 14, 2014

Embryonic Stem Cells Restore Vision In Preliminary Human Test

Isabella Beukes, of Santa Rosa, Calif., has been legally blind for more than 40 years. An experimental treatment derived from embryonic stem cells seems to have enabled her now to see not just color but also some shapes.
Tim Hussin for NPR

Originally published on Fri October 17, 2014 9:39 am

Scientists are reporting the first strong evidence that human embryonic stem cells may be helping patients.

The cells appear to have improved the vision in more than half of the 18 patients who had become legally blind because of two progressive, currently incurable eye diseases.

The researchers stress that the findings must be considered preliminary because the number of patients treated was relatively small and they have only been followed for an average of less than two years.

Read more

Pages